Print this page Email this page
Users Online: 327
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 
ORIGINAL ARTICLE
Year : 2013  |  Volume : 27  |  Issue : 1  |  Page : 31-35

Serum homocysteine in type 2 diabetes with cardiovascular complications


1 Department of Biochemistry, Regional Institute of Medical Sciences, Imphal, Manipur, India
2 Department of Medicine, Regional Institute of Medical Sciences, Imphal, Manipur, India

Correspondence Address:
Maisnam Amuba Singh
Department of Biochemistry, Regional Institute of Medical Sciences, Imphal, Manipur - 795 004
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-4958.116631

Rights and Permissions

Objectives: To determine the association between plasma homocysteine concentration and metabolic parameters in type 2 diabetes mellitus with and without cardiovascular complications. Materials and Methods: Cases of sixty type 2 diabetes mellitus patient (thirty with cardiovascular complications and another thirty without cardiovascular complications) were randomly selected from patients attending Diabetes Clinic and Medical wards, RIMS, Imphal. Another thirty age and sex-matched normal volunteers were taken as control. Serum homocysteine was estimated by ELISA. F-test (ANOVA) and correlation technique were used to analyze the data sets. Results: The serum homocysteine levels of type 2 diabetes mellitus patients both with and without cardiovascular complications were found to be significantly higher (P < 0.001) than the control subjects with 27.20 ± 6.02 μmol/l and 18.03 ± 4.61 μmol/l compared to 9.36 ± 1.70 μmol/l in the controls. Homocysteine is positively correlated with total cholesterol (r = 0.121, P < 0.05) and negatively correlated with HDL level (r= −0.166, P < 0.05). A positive correlation is found between the serum homocysteine level and blood pressure. Conclusions: Homocysteine and dyslipidaemia increases the cardiovascular risk significantly in type 2 diabetes mellitus. Homocysteine may be estimated as a prognostic indicator to assess the risk of developing cardiovascular complications.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2531    
    Printed57    
    Emailed0    
    PDF Downloaded302    
    Comments [Add]    

Recommend this journal